Examine the patient's response and symptom improvement using the Integrated Approach to Symptom Management Model for the patients who has skin toxicity associated with molecularly targeted drug
Not Applicable
- Conditions
- skin toxicity associated with molecularly targeted drug
- Registration Number
- JPRN-UMIN000016947
- Lead Sponsor
- niversity of Hyogo
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who cannot communicate in Japanese and be described to understand the contents of the questionnaire.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method skin condition (adverse events of skin)
- Secondary Outcome Measures
Name Time Method self-efficacy scale for cancer patients Skindex29 self-care ability (scale)